Mercury Surveillance Program by unknown
N 9 4 - 1 3 2
RESPIRATORY PROTECTION PROGRAM
MEDICAL CLEARANCE FOR RESPIRATOR USE
NASA Lewis Research Center
Occupational Medicine Service
Background /- 7
Occupational exposures to various inhalants cause a large portion of occupational
morbidity and mortality. The United States Department of Labor estimates that 65,000
U.S. workers annually develop respiratory disease because of work-related exposures,
and 25,000 people die from these diseases every year. Many, if not all, of these cases
are entirely preventable.
A complete Respiratory Protection Program, as defined by the Occupational
Safety and Health Administration (OSHA) in the CFR 1910.134, includes provision for
on-site hazard control measures incorporating occupational procedures; engineering
controls; and the selection, fitting, use, and care of various kinds of personal respiratory
protective gear. Additionally, health hazards in the workplace need to be identified and
evaluated and permissible exposure limits then need to be ascertained. Methods of
continued environmental monitoring to ensure that the state's permissible exposure limits
(PEL) are not exceeded must be implemented. And always an ongoing priority is the
education of the employee and employer about the toxicity of hazards and the safety
measures designed to protect the worker from these hazards.
To cover all of the components of a Respiratory Protection Program is beyond the
scope of this document and the jurisdiction of the Office of Occupational Medicine
Services (OMS). Rather, this document will cover the rationale, procedures, and
interpretation of results for the medical clearance of employee for use of personal
respiratory protection devices.
The human cardiopulmonary system is a wonderfully complex and yet durable
network directly involving not only the lungs, but the heart and blood vessels as well.
At the most basic level, this system efficiently oxygenates the blood and removes the
waste product, carbon dioxide (CO2). There are many natural built-in defense
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mechanisms such as nose hairs and the cilia-lined mucous membranes of the respiratory
tract that effectively filter larger dust particles from the inhaled air. However, in light
of cardiopulmonary disease, damage to the respiratory tract from cigarette smoke and
other irritants or a high concentration of air contaminants that overwhelm the natural
defense mechanisms, dusts, gases, sprays, vapors, fumes, and even radiation can be
inhaled directly into the lungs. With repeated exposures to these various toxic inhalants,
significant lung damage with measurable clinical effects can be incurred. Often inhalants
have an immediate toxic effect which can even prove fatal, but more frequently the
physical damage becomes evident years after the initial exposure.
Minimizing the inhalation of harmful dusts, fumes, or vapors is the most effective
method of preventing occupational lung diseases. Decreasing the inhalant concentration
is accomplished through engineering control measures, with attention to appropriate
ventilation and safe work practices. When needed, respiratory personal protective
devices (respirators) are used to further minimize inhalant exposures.
There are several varieties of respirators, each with specific criteria for their use.
However, all respirators impose added physiologic burdens on an individual. Not all
people have the pulmonary and/or cardiovascular reserve available to accommodate this
extra physiologic strain. Therefore, medical clearance should be required prior to the
issuance of any respirator and periodically repeated if there is continued respirator use.
Among the physiologic loads imposed by respirators, there is an increase in "dead
space," representing the volume of exhaled air that is rebreathed from the mask with
each inspiration. Rebreathing this dead space air requires either an increased respiratory
rate or an increase in the total volume of air breathed per breath in order to overcome
the dead space effect. If an individual has significant respiratory disease, one or the
other compensatory mechanisms to increase ventilation may not be achievable. Also,
there is a resistance to airflow, especially when using a non-powered air-purifying
respirator, that is called "flow resistive load." Increased pleural pressure must be
generated to overcome the airflow resistance which causes an increase in respiratory
work. If a respirator has significant expiratory impedance then, upon expiration, the
intrathoracic pressure will need to be higher which will also increase the work of
respiration. Increased respiratory work may produce dyspnea (shortness of breath). An
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increase in inspiratory effort will lead to a concomitant decrease in expiratory time,
which may also cause dyspnea.
The increased intrathoracic pressures required to overcome the airflow resistance
will decrease filling of the heart with blood during diastole (relaxation). This may
decrease the cardiac output if the individual does not have the cardiac reserve necessary
to initiate a compensatory increase in heart rate, as described by the equation of cardiac
physiology:
Cardiac output - Stroke volume X Heart rate
Also, myocardial ischemia can occur in individuals with significant coronary artery
disease when the heart rate increases to maintain adequate cardiac output.
Other added stresses imposed by respirators are related to the physical
characteristics of the device itself. The weight of a respirator (SCBA's can weigh up to
30 pounds) will increase energy demands just to carry it, and impose additional strain to
the back and contribute to postural instability. Mobility can be limited by wearing a
respirator. An individual's field of vision and clarity of vision is impeded. Speaking is
difficult while wearing a respirator. Also, there may be a decreased ability to eliminate
heat while wearing a respirator.
Certain pulmonary, cardiovascular, psychiatric, or other diseases may interfere
with respirator use. Pulmonary diseases are generally classified as "restrictive" lung
diseases (pulmonary fibrosis, silicosis, asbestosis, morbid obesity, severe kyphoscoliosis)
and "obstructive" lung diseases (asthma, chronic bronchitis, emphysema, bronchiectasis).
Restrictive lung diseases are characterized by a decrease in lung compliance, and it
therefore may be difficult for these individuals to increase their tidal volume.
Obstructive lung diseases are characterized by an increase in physiologic dead space and
increased airway resistance. Wearing a respirator in either case would only exacerbate
these already existing problems, and could lead to severe dyspnea or even to respiratory
failure. Coronary artery disease and/or cardiac arrhythmias are aggravated in the
presence of hypoxia (low oxygen) or hypercarbia (increased carbon dioxide). Psychiatric
disorders such as certain phobias or personality traits may preclude respirator use or may
make a worker unreliable in using respirators. Other medical conditions can interfere
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with safe respirator use such as perforated tympanic membranes (eardrums), structural
abnormalities of the face (including full beards), and musculoskeletal disorders that make
it difficult to carry the heavier respirators.
Purpose
The purpose of a Respiratory Protection Program at the NASA Lewis Research
Center shall be to:
. Identify those employees who, because of physical disability and/or disease,
should not wear respirators because the added physiological burden of the
respirator would be detrimental to that worker's health or his/her ability to
safely perform their job.
, Educate employees about the necessity of respiratory protection in certain
work environments and how respiratory protection can prevent future
medical problems when used properly.
. Monitor employees who require respiratory protection to ensure that after
an employee has been medically cleared to use a respirator, physical
conditions do not emerge or digress to the point where continued respirator
use would be contraindicated.
Medical Surveillance
In compliance with OSHA policy, all employees who use respirators regularly or
who may use respirators on a emergency basis will have an annual limited physical
examination with spirometry testing. Supervisors of NASA employees who need medical
clearance for respirator use will provide a list of these employees to the Office of
Environmental Program who, in turn, will share this list with the Occupational Medicine
Services Office. The limited medical exams can be incorporated with the annual health
screening physicals that are available to all NASA employees.
A Respiratory History for Spirometry Questionnaire will be completed by the
employee. Any employee who has had a respiratory infection within three weeks before
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the spirometry testing will be rescheduled. Additional medical history will be obtained
during the physical that will concentrate on pulmonary, cardiovascular, neuromuscular,
or physical problems which can adversely affect safe respirator use.
The physical exam for respirator clearance will concentrate on obtaining the
employee's vital signs (blood pressure, pulse, respiratory rate, and temperature) and
close examination of the employee's head, eyes, ears, nose, throat, mouth, neck, heart,
lungs, and chest wall.
Spirometry testing will be obtained to calculate the employee's forced vital
capacity (FVC), forced expiratory volume in one second (FEV1), and FEV1/FVC (or
FEV 1%). While several other calculated values are extrapolated from spirometry testing,
these three values best reflect an individual's functional lung capacity. When these three
values are abnormal, the other values may then be of more value in the interpretation of
the spirometry results, and additional tests may be indicated (e.g., chest X-ray, arterial
blood gas sampling, diffusion capacity calculation, etc.). The spirometer that is used,
the calibration of this instrument, and the interpretation of the results will comply with
the "Standards for Administration and Interpretation of Ventilatory Function Tests,"
developed by OSHA in consultation with NIOSH (Federal Register, Rules and
Regulations, Vol. 45, No. 42, Appendix B, pp 13695-13696).
An employee's spirometric test results will be compared to a set of reference
standards and also compared to that employee's previous studies, if available. If the
spirometry results are abnormal, repeat spirometry testing will be scheduled. If there is
a significant decrement in an employee's pulmonary function when compared to previous
studies, even if the employee's results fall within "normal limits," a repeat spirometry
test will be scheduled. No more than two spirometry tests will be scheduled in a given
calendar year if solely for the purpose of respirator clearance. "Normal" spirometry
results are outlined in Table 1. Contraindications for respirator use are outlined in Table
,
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Table 1. Normal Spirometry Results
FVC
FEV 1
FEV 1%
(FEV1/FVC)
> 80% Age Predicted Value
> 80% Age Predicted Value
> 70 % (Actual Value)
Table 2. Contraindications for Respirator Usage
.
.
,
4.
5.
.
7.
,
9.
10.
11.
12.
Spirometry results fall below those values documented in
Table 2.
Uncontrolled cardiovascular disease (angina, valvular heart
disease, known coronary artery disease, hypertension, or
extmcranial vascular disease).
Uncontrolled epilepsy.
Syncopal episodes.
Myasthenia gmvis, or other fatiguing neuromuscular
disorders.
Sleep apnea.
Facial deformity (including the presence of beards) that
render respirator fitting difficult, and adequacy of the
seal cannot be guaranteed.
Ill-fitting dentures.
Severe kyphoscoliosis.
Morbid obesity.
Psychiatric disorders where reliability of respirator usage
cannot be guaranteed.
Perceived severe dyspnea (shortness of breath) when
respirator is worn.
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All employees who meet the medical criteria for respirator usage will have a
certificate sent to their supervisor with a copy sent to the Office of Environmental
Programs. Similarly, employees who do not meet the criteria for respirator usage will
have a certificate sent to their supervisor and the Office of Environmental Programs.
°
2.
.
.
.
6.
.
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